Mutant CsgG pores
First Claim
Patent Images
1. An apparatus for characterizing a target analyte, the apparatus comprising a mutant CsgG monomer comprising a variant of the sequence shown in SEQ ID NO:
- 390, wherein the variant comprises a mutation at one or more of positions Y51, N55 and F56, and an in vitro membrane, wherein the monomer is inserted into the in vitro membrane.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to mutant forms of the outer membrane-located lipoprotein CsgG, in particular, modifications at one or more of positions Tyr51; Asn55; and Phe56. The invention also relates to analyte detection and characterisation using said mutant CsgG.
132 Citations
8 Claims
-
1. An apparatus for characterizing a target analyte, the apparatus comprising a mutant CsgG monomer comprising a variant of the sequence shown in SEQ ID NO:
- 390, wherein the variant comprises a mutation at one or more of positions Y51, N55 and F56, and an in vitro membrane, wherein the monomer is inserted into the in vitro membrane.
- View Dependent Claims (2, 3, 4, 5)
-
6. An apparatus for characterizing a target analyte, the apparatus comprising a plurality of mutant CsgG monomers, each monomer comprising a variant of the sequence shown in SEQ ID NO:
- 390, wherein each variant comprises a mutation at one or more of positions Y51, N55 and F56, and wherein the plurality of monomers is inserted into a plurality of in vitro membranes.
- View Dependent Claims (7, 8)
Specification